Vascepa
Drug - Vascepa [Amarin Pharma, Inc.]
June 2013
Therapeutic area - Cardiovascular
Approval criteria
- Patient has a documented triglyceride level >1000 mg/dL AND
- Patient has tried and failed fenofibrate AND
- Patient has tried and failed Lovaza
Questions?
MHCP Provider Call Center 651-431-2700 or 800-366-5411